Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease ; volume:9 ; number:1 ; day:11 ; month:5 ; year:2016 ; pages:1-8 ; date:12.2016
BMC Research Notes / Biomed Central; 9, Heft 1 (11.5.2016), 1-8, 12.2016
- Urheber
-
Hossain, Israt Ara
- Beteiligte Personen und Organisationen
-
Akter, Salima
Bhuiyan, Farjana Rahman
Shah, Mijanur Rahman
Rahman, Mohammad Khalilur
Ali, Liaquat
SpringerLink (Online service)
- DOI
-
10.1186/s13104-016-2071-x
- URN
-
urn:nbn:de:1111-201605132931
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hossain, Israt Ara
- Akter, Salima
- Bhuiyan, Farjana Rahman
- Shah, Mijanur Rahman
- Rahman, Mohammad Khalilur
- Ali, Liaquat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Correction to: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Correction to: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
Thyroid dysfunction and insulin resistance in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Correction to: A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old